new antibiotic, Ketek (telithromycin)

Aventis will promote a new antibiotic, Ketek (telithromycin).

It's the first of a new class...called ketolides. These are similar to macrolides such as erythromycin.

Ketek is approved for community-acquired pneumonia... exacerbations of chronic bronchitis...and sinusitis.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote